Abstract：Objective To investigate the effect of Rosuvastatin on inflammatory factors and short-term prognosis in patients with unstable angina pectoris (UAP).Methods From November 2018 to April 2019,80 patients with UAP treated in our hospital were selected and randomly divided into experimental group (n=40) and control group (n=40).The experimental group was given Rosuvastatin 10 mg/time,once a day,while the control group was given Atorvastatin 20 mg/time,once a day.The levels of serum lipids,levels of high sensitivity C-reactive protein (hs-CRP),interleukin-12 (IL-12)and interleukin-23 (IL-23) were measured before treatment and 4 weeks after treatment.Results Before treatment,The total cholesterol (TC),triglyceride (TG),low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C),hs-CRP,IL-12 and IL-23 levels of two groups had no significant difference (P＜0.05).Four weeks after treatment,the levels of TC,TG,LDL-C,hs-CRP,IL-12 and IL-23 in the two groups were lower than those before treatment,and the differences were statistically significant (P＜0.05).The level of HDL-C in the control group was higher than that before treatment,and the difference was statistically significant (P＜0.05).Four weeks of after treatment,the levels of TC,TG,hs-CRP and IL-12 in the experimental group were lower than those in the control group,the differences were statistically significant (P＜0.05).Conclusion Rosuvastatin has more significant effect in improving blood lipid and inflammatory factors in patients with UAP,which is worthy of clinical application.
van der Vorst EP，Doring Y，Weber C.MIF and CXCL12 in cardiovascular diseases：functional differences and similarities[J].Front Immunol，2015，373（8）：1475-1478.
[2]
Khera AV，Emdin CA，Drake I，et al.Genetic risk，adherence to a healthy lifestyle，and coronary disease[J].N Engl J Med，2016，375（24）：2349-2358.
Arnaud C，Burger F，Steffens S，et al.Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes： new evidence for direct antiinflammatory effects of statins[J].Arterioscler Thromb Vasc Biol，2005，25（6）：1231-1236.
[11]
Voleti B，Agrawal A.Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist[J].Mol Immunol，2006，43（7）：891-896.
[12]
Mayer C，Gruber HJ，Landl EM，et al.Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3-and C/EBP-dependent fashion[J].Int J Clin Pharmacol Ther，2007，45（6）：319-327.
京公网安备 11010502046607号